Imaging Diagnostic Systems Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Imaging Diagnostic Systems Inc (IMDS) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Imaging Diagnostic Systems Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 0M vs 124,319M combined for tracked competitors (0.0% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-73.7% annualized vs trailing 12 months), vs decelerating (-23.0%) for its tracked peer group.
- Profitability: Its -1,499.8% net margin compares with 11.3% for the peer group.
- Peer revenue share: Imaging Diagnostic Systems Inc accounted for 0.0% of combined revenue among its tracked peer group.
- Peer differentiation: Revenue per employee of $0.02M compares with $0.34M for the peer group (0.0x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
IMDS Sales vs. its Competitors, Q1 2024
With a net margin of -1,499.77 %, Imaging Diagnostic Systems Inc reported lower profitability than its competitors (11.27 %).
Imaging Diagnostic Systems Inc generated 0.00 % of the combined sales of its peer group.
Imaging Diagnostic Systems Inc vs. its Competitors, Q1 2024
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Imaging Diagnostic Systems Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Imaging Diagnostic Systems Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Imaging Diagnostic Systems Inc's competitor groups requires a Commercial License.
Imaging Diagnostic Systems Inc's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Imaging Diagnostic Systems Inc | - | - | - | Yes |
| Competitors combined (34) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
IMDS Stock Performance relative to its Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Icad Inc | 282.9% | Outperformed |
| 2 | Pulse Biosciences Inc | 282.9% | Outperformed |
| 3 | Establishment Labs Holdings Inc | 282.9% | Outperformed |
| 4 | Fonar Corporation | 282.9% | Outperformed |
| 5 | Becton Dickinson And Company | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Imaging Diagnostic Systems Inc's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Imaging Diagnostic Systems Inc's Comment on Competition and Industry Peers
Publicly Traded Peers of Imaging Diagnostic Systems Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Imaging Diagnostic Systems Inc | - | 0.16 |
| Medtronic Plc | 110,891.28 | 37,542.00 |
| Boston Scientific Corporation | 64,375.02 | 20,997.00 |
| Becton Dickinson And Company | 49,253.28 | 20,840.00 |
| Ge Healthcare Technologies Inc | 29,874.09 | 17,475.00 |
| Koninklijke Philips Nv | 23,513.95 | 20,163.51 |
| SUBTOTAL | 303,224.26 | 124,382.81 |
Sign in to see all competitors of Imaging Diagnostic Systems Inc.
Sources: Imaging Diagnostic Systems Inc's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Imaging Diagnostic Systems Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Imaging Diagnostic Systems Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Medtronic Plc | CARDIOVASCULAR 38.34 % |
| Boston Scientific Corporation | Cardiovascular 67.31 % |
| Becton Dickinson And Company | Medical Essentials 34.94 % |
| Ge Healthcare Technologies Inc | Radiology Subsegment 53.17 % |
| Hologic Inc | Diagnostics 51.18 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Sign in to see all peers for Imaging Diagnostic Systems Inc.
Imaging Diagnostic Systems Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Imaging Diagnostic Systems Inc | - | 16,178 | -29,248 |
| Medtronic Plc | 110,891 | 395,179 | 55,463 |
| Boston Scientific Corporation | 64,375 | 355,881 | 62,186 |
| Becton Dickinson And Company | 49,253 | 289,444 | 13,069 |
| Ge Healthcare Technologies Inc | 29,874 | 323,611 | 36,611 |
| Koninklijke Philips Nv | 23,514 | 294,706 | 14,823 |
| PEERS TOTAL | 303,224 | 344,047 | 34,929 |
Sign in to see all peers for Imaging Diagnostic Systems Inc.
Imaging Diagnostic Systems Inc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Medtronic Plc | United States 49.83 % |
| Boston Scientific Corporation | United States 63.11 % |
| Becton Dickinson And Company | United States 61.88 % |
| Hologic Inc | Non-US 30.23 % |
| Establishment Labs Holdings Inc | Non-US 63.44 % |
Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Sign in to see all peers for Imaging Diagnostic Systems Inc.
Imaging Diagnostic Systems Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - |
| Return on Invested Capital | - | 94.93 % | 27.80 % | 16.07 % | 13.16 % | 5.03 % |
| P/E | - | - | - | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Imaging Diagnostic Systems Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
No rule matched.
Weaknesses
- Latest-quarter revenue run-rate is decelerating (-73.7% annualized vs trailing 12 months).
- Piotroski F-Score of 2 or below, the standard financial-distress signal.
Opportunities
- A meaningful share of tracked competitors (35.50 %) show financial-distress signals, a possible opening to gain share.
Threats
- Tracked peer group's revenue run-rate is broadly decelerating (-23.0% annualized).
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Imaging Diagnostic Systems Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Imaging Diagnostic Systems Inc | 0.00 | 0.00 | - |
| Medtronic Plc | 0.15 | 2.10 | 0.57 |
| Boston Scientific Corporation | 0.25 | 1.54 | 0.47 |
| Becton Dickinson And Company | 0.10 | 1.00 | 0.73 |
| Ge Healthcare Technologies Inc | - | 1.23 | 1.00 |
| Koninklijke Philips Nv | 0.37 | 1.32 | 0.73 |
Sign in to see all peers for Imaging Diagnostic Systems Inc.
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Imaging Diagnostic Systems Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Imaging Diagnostic Systems Inc | Q3 2024 | - | - |
| Medtronic Plc | Q2 2026 | +13.7 % | +41.3 % |
| Boston Scientific Corporation | Q2 2026 | +7.5 % | +13.8 % |
| Becton Dickinson And Company | Q2 2026 | +5.4 % | -34.3 % |
| Ge Healthcare Technologies Inc | Q1 2026 | +7.2 % | -30.1 % |
| Koninklijke Philips Nv | Q4 2025 | +3.4 % | - |
| PEERS TOTAL | +7.2 % | +73.7 % |
Sign in to see all peers for Imaging Diagnostic Systems Inc.
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Imaging Diagnostic Systems Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Imaging Diagnostic Systems Inc | Q3 2024 | - | - |
| Medtronic Plc | Q2 2026 | +13.8 % | -0.2 % |
| Boston Scientific Corporation | Q2 2026 | -2.6 % | +24.2 % |
| Becton Dickinson And Company | Q2 2026 | +7.1 % | -12.8 % |
| Ge Healthcare Technologies Inc | Q1 2026 | +16.3 % | +17.1 % |
| Koninklijke Philips Nv | Q4 2025 | +4.6 % | -11.3 % |
Sign in to see all peers for Imaging Diagnostic Systems Inc.
Imaging Diagnostic Systems Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Imaging Diagnostic Systems Inc | - | - | - |
| Medtronic Plc | 5.71% | 6.46% | 10.64% |
| Boston Scientific Corporation | 8.34% | 9.91% | 14.77% |
| Becton Dickinson And Company | 1.77% | 2.22% | 3.79% |
| Ge Healthcare Technologies Inc | 5.43% | 7.29% | 19.37% |
| Koninklijke Philips Nv | 3.21% | 3.86% | 7.86% |
Sign in to see all peers for Imaging Diagnostic Systems Inc.
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Imaging Diagnostic Systems Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Imaging Diagnostic Systems Inc | - | - |
| Medtronic Plc | 253.79 | 2.95 |
| Boston Scientific Corporation | 17.69 | 3.07 |
| Becton Dickinson And Company | 54.08 | 2.36 |
| Ge Healthcare Technologies Inc | 15.68 | 1.71 |
| Koninklijke Philips Nv | 26.27 | 1.17 |
| PEERS AVERAGE | 24.01 | 2.44 |
Sign in to see all peers for Imaging Diagnostic Systems Inc.
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.